华纳药厂：公司多款产品参与药品集中采购拟中标

Core Viewpoint - Warner Pharmaceuticals (688799) has participated in national and regional centralized procurement for traditional Chinese medicine and chemical drugs, indicating a strategic move to enhance market presence and secure contracts in the pharmaceutical sector [1] Group 1: Procurement Participation - The company announced its participation in the national centralized procurement organized by the National Traditional Chinese Medicine Joint Procurement Office [1] - Additionally, the company took part in the Hebei Provincial Medical Drug and Device Centralized Procurement Center's bidding for the Beijing-Tianjin-Hebei-Jiangxi chemical drug centralized procurement [1] Group 2: Tender Results - According to the selection results, the company’s Ginkgo Biloba tablets, Fosfomycin Ammonium Trihydrate granules, and Diclofenac Sodium sustained-release tablets are expected to win bids [1]